nodes	percent_of_prediction	percent_of_DWPC	metapath
Stavudine—Floxuridine—TYMP—esophageal cancer	0.0516	0.496	CrCbGaD
Stavudine—Guillain-Barre syndrome—Methotrexate—esophageal cancer	0.0411	0.0459	CcSEcCtD
Stavudine—Trifluridine—TYMP—esophageal cancer	0.041	0.394	CrCbGaD
Stavudine—Neurological symptom—Cisplatin—esophageal cancer	0.036	0.0402	CcSEcCtD
Stavudine—Peripheral sensory neuropathy—Capecitabine—esophageal cancer	0.0281	0.0313	CcSEcCtD
Stavudine—Hepatic steatosis—Capecitabine—esophageal cancer	0.0265	0.0296	CcSEcCtD
Stavudine—Polyneuropathy—Capecitabine—esophageal cancer	0.0246	0.0274	CcSEcCtD
Stavudine—Osteonecrosis—Methotrexate—esophageal cancer	0.016	0.0179	CcSEcCtD
Stavudine—Opportunistic infection—Methotrexate—esophageal cancer	0.0148	0.0165	CcSEcCtD
Stavudine—Hepatotoxicity—Cisplatin—esophageal cancer	0.0141	0.0157	CcSEcCtD
Stavudine—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.014	0.0156	CcSEcCtD
Stavudine—Blood triglycerides increased—Capecitabine—esophageal cancer	0.0122	0.0137	CcSEcCtD
Stavudine—Haemoglobin decreased—Capecitabine—esophageal cancer	0.0116	0.013	CcSEcCtD
Stavudine—Hepatomegaly—Capecitabine—esophageal cancer	0.0113	0.0126	CcSEcCtD
Stavudine—Pain—Carboplatin—esophageal cancer	0.0113	0.0126	CcSEcCtD
Stavudine—Hepatocellular injury—Cisplatin—esophageal cancer	0.0109	0.0121	CcSEcCtD
Stavudine—Body temperature increased—Carboplatin—esophageal cancer	0.0105	0.0117	CcSEcCtD
Stavudine—Fungal infection—Capecitabine—esophageal cancer	0.0104	0.0116	CcSEcCtD
Stavudine—Hepatotoxicity—Capecitabine—esophageal cancer	0.0104	0.0116	CcSEcCtD
Stavudine—Neuropathy—Cisplatin—esophageal cancer	0.0102	0.0114	CcSEcCtD
Stavudine—Tingling sensation—Capecitabine—esophageal cancer	0.00997	0.0111	CcSEcCtD
Stavudine—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00882	0.00984	CcSEcCtD
Stavudine—Liver disorder—Methotrexate—esophageal cancer	0.00875	0.00977	CcSEcCtD
Stavudine—Lung disorder—Methotrexate—esophageal cancer	0.00843	0.00941	CcSEcCtD
Stavudine—Zidovudine—CYP2A6—esophageal cancer	0.00831	0.08	CrCbGaD
Stavudine—Inflammation—Capecitabine—esophageal cancer	0.00826	0.00922	CcSEcCtD
Stavudine—Fungal infection—Methotrexate—esophageal cancer	0.00773	0.00862	CcSEcCtD
Stavudine—Hepatotoxicity—Methotrexate—esophageal cancer	0.00773	0.00862	CcSEcCtD
Stavudine—Neuropathy—Capecitabine—esophageal cancer	0.00753	0.0084	CcSEcCtD
Stavudine—Mouth ulceration—Capecitabine—esophageal cancer	0.00725	0.00809	CcSEcCtD
Stavudine—Mental disability—Capecitabine—esophageal cancer	0.00696	0.00776	CcSEcCtD
Stavudine—Diabetes mellitus—Capecitabine—esophageal cancer	0.00669	0.00747	CcSEcCtD
Stavudine—Pancreatitis—Cisplatin—esophageal cancer	0.00669	0.00747	CcSEcCtD
Stavudine—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00666	0.00743	CcSEcCtD
Stavudine—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00656	0.00732	CcSEcCtD
Stavudine—Hepatic failure—Capecitabine—esophageal cancer	0.00647	0.00723	CcSEcCtD
Stavudine—Inflammation—Methotrexate—esophageal cancer	0.00615	0.00687	CcSEcCtD
Stavudine—Respiratory failure—Methotrexate—esophageal cancer	0.00608	0.00678	CcSEcCtD
Stavudine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00596	0.00665	CcSEcCtD
Stavudine—Stomatitis—Cisplatin—esophageal cancer	0.00593	0.00662	CcSEcCtD
Stavudine—Conjunctivitis—Cisplatin—esophageal cancer	0.00591	0.0066	CcSEcCtD
Stavudine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00575	0.00642	CcSEcCtD
Stavudine—Mood swings—Capecitabine—esophageal cancer	0.00551	0.00615	CcSEcCtD
Stavudine—Mouth ulceration—Methotrexate—esophageal cancer	0.0054	0.00602	CcSEcCtD
Stavudine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00537	0.00599	CcSEcCtD
Stavudine—Gynaecomastia—Methotrexate—esophageal cancer	0.00534	0.00596	CcSEcCtD
Stavudine—Dry skin—Capecitabine—esophageal cancer	0.00533	0.00595	CcSEcCtD
Stavudine—Influenza—Capecitabine—esophageal cancer	0.00503	0.00561	CcSEcCtD
Stavudine—Diabetes mellitus—Methotrexate—esophageal cancer	0.00498	0.00556	CcSEcCtD
Stavudine—Bronchitis—Capecitabine—esophageal cancer	0.00484	0.0054	CcSEcCtD
Stavudine—Hepatic failure—Methotrexate—esophageal cancer	0.00482	0.00538	CcSEcCtD
Stavudine—Malnutrition—Cisplatin—esophageal cancer	0.00475	0.00531	CcSEcCtD
Stavudine—Dysuria—Capecitabine—esophageal cancer	0.0047	0.00525	CcSEcCtD
Stavudine—Neutropenia—Capecitabine—esophageal cancer	0.0047	0.00525	CcSEcCtD
Stavudine—Flatulence—Cisplatin—esophageal cancer	0.00468	0.00523	CcSEcCtD
Stavudine—Weight decreased—Capecitabine—esophageal cancer	0.00455	0.00508	CcSEcCtD
Stavudine—Hyperglycaemia—Capecitabine—esophageal cancer	0.00454	0.00506	CcSEcCtD
Stavudine—Depression—Capecitabine—esophageal cancer	0.00447	0.00499	CcSEcCtD
Stavudine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.0044	0.00491	CcSEcCtD
Stavudine—Anaemia—Cisplatin—esophageal cancer	0.00439	0.0049	CcSEcCtD
Stavudine—Jaundice—Capecitabine—esophageal cancer	0.00437	0.00488	CcSEcCtD
Stavudine—Stomatitis—Capecitabine—esophageal cancer	0.00437	0.00488	CcSEcCtD
Stavudine—Conjunctivitis—Capecitabine—esophageal cancer	0.00436	0.00486	CcSEcCtD
Stavudine—Urinary tract infection—Capecitabine—esophageal cancer	0.00436	0.00486	CcSEcCtD
Stavudine—Haematuria—Capecitabine—esophageal cancer	0.00428	0.00477	CcSEcCtD
Stavudine—Leukopenia—Cisplatin—esophageal cancer	0.00426	0.00475	CcSEcCtD
Stavudine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00424	0.00473	CcSEcCtD
Stavudine—Mood swings—Methotrexate—esophageal cancer	0.0041	0.00458	CcSEcCtD
Stavudine—Myalgia—Cisplatin—esophageal cancer	0.00405	0.00452	CcSEcCtD
Stavudine—Rhinitis—Capecitabine—esophageal cancer	0.00404	0.0045	CcSEcCtD
Stavudine—Anxiety—Cisplatin—esophageal cancer	0.00403	0.0045	CcSEcCtD
Stavudine—Hepatitis—Capecitabine—esophageal cancer	0.00403	0.00449	CcSEcCtD
Stavudine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00402	0.00449	CcSEcCtD
Stavudine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00401	0.00447	CcSEcCtD
Stavudine—Pharyngitis—Capecitabine—esophageal cancer	0.004	0.00446	CcSEcCtD
Stavudine—Connective tissue disorder—Capecitabine—esophageal cancer	0.00396	0.00441	CcSEcCtD
Stavudine—Nervous system disorder—Cisplatin—esophageal cancer	0.0038	0.00425	CcSEcCtD
Stavudine—Thrombocytopenia—Cisplatin—esophageal cancer	0.0038	0.00424	CcSEcCtD
Stavudine—Skin disorder—Cisplatin—esophageal cancer	0.00377	0.00421	CcSEcCtD
Stavudine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00375	0.00419	CcSEcCtD
Stavudine—Anorexia—Cisplatin—esophageal cancer	0.0037	0.00413	CcSEcCtD
Stavudine—Pancreatitis—Methotrexate—esophageal cancer	0.00367	0.0041	CcSEcCtD
Stavudine—Chills—Capecitabine—esophageal cancer	0.00361	0.00403	CcSEcCtD
Stavudine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00353	0.00394	CcSEcCtD
Stavudine—Mental disorder—Capecitabine—esophageal cancer	0.00353	0.00394	CcSEcCtD
Stavudine—Malnutrition—Capecitabine—esophageal cancer	0.0035	0.00391	CcSEcCtD
Stavudine—Neutropenia—Methotrexate—esophageal cancer	0.0035	0.00391	CcSEcCtD
Stavudine—Dysuria—Methotrexate—esophageal cancer	0.0035	0.00391	CcSEcCtD
Stavudine—Paraesthesia—Cisplatin—esophageal cancer	0.00348	0.00389	CcSEcCtD
Stavudine—Flatulence—Capecitabine—esophageal cancer	0.00345	0.00385	CcSEcCtD
Stavudine—Dysgeusia—Capecitabine—esophageal cancer	0.00343	0.00383	CcSEcCtD
Stavudine—Back pain—Capecitabine—esophageal cancer	0.00339	0.00378	CcSEcCtD
Stavudine—Decreased appetite—Cisplatin—esophageal cancer	0.00337	0.00376	CcSEcCtD
Stavudine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00335	0.00374	CcSEcCtD
Stavudine—Depression—Methotrexate—esophageal cancer	0.00333	0.00371	CcSEcCtD
Stavudine—Pain—Cisplatin—esophageal cancer	0.00332	0.0037	CcSEcCtD
Stavudine—Stomatitis—Methotrexate—esophageal cancer	0.00325	0.00363	CcSEcCtD
Stavudine—Conjunctivitis—Methotrexate—esophageal cancer	0.00324	0.00362	CcSEcCtD
Stavudine—Anaemia—Capecitabine—esophageal cancer	0.00324	0.00361	CcSEcCtD
Stavudine—Sweating—Methotrexate—esophageal cancer	0.0032	0.00357	CcSEcCtD
Stavudine—Haematuria—Methotrexate—esophageal cancer	0.00318	0.00355	CcSEcCtD
Stavudine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00316	0.00352	CcSEcCtD
Stavudine—Leukopenia—Capecitabine—esophageal cancer	0.00314	0.0035	CcSEcCtD
Stavudine—Zidovudine—ABCB1—esophageal cancer	0.0031	0.0298	CrCbGaD
Stavudine—Body temperature increased—Cisplatin—esophageal cancer	0.00307	0.00342	CcSEcCtD
Stavudine—Cough—Capecitabine—esophageal cancer	0.00306	0.00341	CcSEcCtD
Stavudine—Hepatitis—Methotrexate—esophageal cancer	0.003	0.00334	CcSEcCtD
Stavudine—Arthralgia—Capecitabine—esophageal cancer	0.00298	0.00333	CcSEcCtD
Stavudine—Myalgia—Capecitabine—esophageal cancer	0.00298	0.00333	CcSEcCtD
Stavudine—Pharyngitis—Methotrexate—esophageal cancer	0.00297	0.00332	CcSEcCtD
Stavudine—Anxiety—Capecitabine—esophageal cancer	0.00297	0.00332	CcSEcCtD
Stavudine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00296	0.00331	CcSEcCtD
Stavudine—Dry mouth—Capecitabine—esophageal cancer	0.00292	0.00326	CcSEcCtD
Stavudine—Hypersensitivity—Cisplatin—esophageal cancer	0.00286	0.00319	CcSEcCtD
Stavudine—Nervous system disorder—Capecitabine—esophageal cancer	0.0028	0.00313	CcSEcCtD
Stavudine—Thrombocytopenia—Capecitabine—esophageal cancer	0.0028	0.00313	CcSEcCtD
Stavudine—Asthenia—Cisplatin—esophageal cancer	0.00278	0.00311	CcSEcCtD
Stavudine—Skin disorder—Capecitabine—esophageal cancer	0.00278	0.0031	CcSEcCtD
Stavudine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00276	0.00309	CcSEcCtD
Stavudine—Anorexia—Capecitabine—esophageal cancer	0.00273	0.00304	CcSEcCtD
Stavudine—Chills—Methotrexate—esophageal cancer	0.00269	0.003	CcSEcCtD
Stavudine—Diarrhoea—Cisplatin—esophageal cancer	0.00265	0.00296	CcSEcCtD
Stavudine—Mental disorder—Methotrexate—esophageal cancer	0.00263	0.00293	CcSEcCtD
Stavudine—Malnutrition—Methotrexate—esophageal cancer	0.00261	0.00291	CcSEcCtD
Stavudine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00261	0.00291	CcSEcCtD
Stavudine—Insomnia—Capecitabine—esophageal cancer	0.00259	0.00289	CcSEcCtD
Stavudine—Paraesthesia—Capecitabine—esophageal cancer	0.00257	0.00287	CcSEcCtD
Stavudine—Dysgeusia—Methotrexate—esophageal cancer	0.00255	0.00285	CcSEcCtD
Stavudine—Back pain—Methotrexate—esophageal cancer	0.00252	0.00282	CcSEcCtD
Stavudine—Dyspepsia—Capecitabine—esophageal cancer	0.00252	0.00281	CcSEcCtD
Stavudine—Decreased appetite—Capecitabine—esophageal cancer	0.00249	0.00277	CcSEcCtD
Stavudine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00247	0.00276	CcSEcCtD
Stavudine—Vomiting—Cisplatin—esophageal cancer	0.00247	0.00275	CcSEcCtD
Stavudine—Fatigue—Capecitabine—esophageal cancer	0.00247	0.00275	CcSEcCtD
Stavudine—Rash—Cisplatin—esophageal cancer	0.00245	0.00273	CcSEcCtD
Stavudine—Constipation—Capecitabine—esophageal cancer	0.00245	0.00273	CcSEcCtD
Stavudine—Pain—Capecitabine—esophageal cancer	0.00245	0.00273	CcSEcCtD
Stavudine—Dermatitis—Cisplatin—esophageal cancer	0.00244	0.00273	CcSEcCtD
Stavudine—Anaemia—Methotrexate—esophageal cancer	0.00241	0.00269	CcSEcCtD
Stavudine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00234	0.00261	CcSEcCtD
Stavudine—Leukopenia—Methotrexate—esophageal cancer	0.00234	0.00261	CcSEcCtD
Stavudine—Nausea—Cisplatin—esophageal cancer	0.0023	0.00257	CcSEcCtD
Stavudine—Cough—Methotrexate—esophageal cancer	0.00228	0.00254	CcSEcCtD
Stavudine—Urticaria—Capecitabine—esophageal cancer	0.00227	0.00254	CcSEcCtD
Stavudine—Body temperature increased—Capecitabine—esophageal cancer	0.00226	0.00252	CcSEcCtD
Stavudine—Abdominal pain—Capecitabine—esophageal cancer	0.00226	0.00252	CcSEcCtD
Stavudine—Arthralgia—Methotrexate—esophageal cancer	0.00222	0.00248	CcSEcCtD
Stavudine—Myalgia—Methotrexate—esophageal cancer	0.00222	0.00248	CcSEcCtD
Stavudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00221	0.00246	CcSEcCtD
Stavudine—Hypersensitivity—Capecitabine—esophageal cancer	0.00211	0.00235	CcSEcCtD
Stavudine—Nervous system disorder—Methotrexate—esophageal cancer	0.00209	0.00233	CcSEcCtD
Stavudine—Thrombocytopenia—Methotrexate—esophageal cancer	0.00208	0.00233	CcSEcCtD
Stavudine—Skin disorder—Methotrexate—esophageal cancer	0.00207	0.00231	CcSEcCtD
Stavudine—Hyperhidrosis—Methotrexate—esophageal cancer	0.00206	0.0023	CcSEcCtD
Stavudine—Asthenia—Capecitabine—esophageal cancer	0.00205	0.00229	CcSEcCtD
Stavudine—Anorexia—Methotrexate—esophageal cancer	0.00203	0.00226	CcSEcCtD
Stavudine—Pruritus—Capecitabine—esophageal cancer	0.00202	0.00226	CcSEcCtD
Stavudine—Diarrhoea—Capecitabine—esophageal cancer	0.00196	0.00218	CcSEcCtD
Stavudine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00194	0.00216	CcSEcCtD
Stavudine—Insomnia—Methotrexate—esophageal cancer	0.00193	0.00215	CcSEcCtD
Stavudine—Paraesthesia—Methotrexate—esophageal cancer	0.00191	0.00213	CcSEcCtD
Stavudine—Somnolence—Methotrexate—esophageal cancer	0.00189	0.00211	CcSEcCtD
Stavudine—Dizziness—Capecitabine—esophageal cancer	0.00189	0.00211	CcSEcCtD
Stavudine—Dyspepsia—Methotrexate—esophageal cancer	0.00187	0.00209	CcSEcCtD
Stavudine—Decreased appetite—Methotrexate—esophageal cancer	0.00185	0.00207	CcSEcCtD
Stavudine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00184	0.00205	CcSEcCtD
Stavudine—Fatigue—Methotrexate—esophageal cancer	0.00184	0.00205	CcSEcCtD
Stavudine—Pain—Methotrexate—esophageal cancer	0.00182	0.00203	CcSEcCtD
Stavudine—Vomiting—Capecitabine—esophageal cancer	0.00182	0.00203	CcSEcCtD
Stavudine—Rash—Capecitabine—esophageal cancer	0.0018	0.00201	CcSEcCtD
Stavudine—Dermatitis—Capecitabine—esophageal cancer	0.0018	0.00201	CcSEcCtD
Stavudine—Headache—Capecitabine—esophageal cancer	0.00179	0.002	CcSEcCtD
Stavudine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00174	0.00194	CcSEcCtD
Stavudine—Nausea—Capecitabine—esophageal cancer	0.0017	0.0019	CcSEcCtD
Stavudine—Urticaria—Methotrexate—esophageal cancer	0.00169	0.00189	CcSEcCtD
Stavudine—Abdominal pain—Methotrexate—esophageal cancer	0.00168	0.00188	CcSEcCtD
Stavudine—Body temperature increased—Methotrexate—esophageal cancer	0.00168	0.00188	CcSEcCtD
Stavudine—Hypersensitivity—Methotrexate—esophageal cancer	0.00157	0.00175	CcSEcCtD
Stavudine—Asthenia—Methotrexate—esophageal cancer	0.00153	0.0017	CcSEcCtD
Stavudine—Pruritus—Methotrexate—esophageal cancer	0.00151	0.00168	CcSEcCtD
Stavudine—Diarrhoea—Methotrexate—esophageal cancer	0.00146	0.00163	CcSEcCtD
Stavudine—Dizziness—Methotrexate—esophageal cancer	0.00141	0.00157	CcSEcCtD
Stavudine—Vomiting—Methotrexate—esophageal cancer	0.00135	0.00151	CcSEcCtD
Stavudine—Rash—Methotrexate—esophageal cancer	0.00134	0.0015	CcSEcCtD
Stavudine—Dermatitis—Methotrexate—esophageal cancer	0.00134	0.0015	CcSEcCtD
Stavudine—Headache—Methotrexate—esophageal cancer	0.00133	0.00149	CcSEcCtD
Stavudine—Nausea—Methotrexate—esophageal cancer	0.00126	0.00141	CcSEcCtD
